This briefing explains digital twin technology and how they are used in different sectors. It also outlines how the UK is investing to develop national capability in this technology, and the associated opportunities and challenges for its wider application.
This briefing discusses cyber security risks to elections. It explores the potential impacts on election outcomes and how these risks can be tackled.
Researchers are exploring the role of psychedelic drugs as a treatment for addictions. How are addiction disorders currently treated and what does the latest research on psychedelic drugs show?
Rapid response
What are the effects of AI for decision making, workplace rights, transparency, surveillance, civil liberties and intellectual property?
Rapid response
What are the challenges of public opinion polling in advance of a general election? Who regulates it, and does it have an impact on the public?
Rapid response
Researchers are exploring the role of psychedelic drugs as a treatment for eating disorders. How are eating disorders currently treated and what does the latest research on psychedelic drugs show?
Rapid response
How is PTSD treated, how successful are current treatments and what is the potential role for psychedelic-assisted therapy?
Rapid response
The number of people voting in elections is an indicator of democratic health. In UK general elections, this number has declined since 1997. Why is this? What could be done to increase turnout?
Rapid response
How are anxiety disorders treated, how successful are current treatments and what is the potential role for psychedelic-assisted therapy?
Rapid response
Researchers are exploring the science of psychedelic drugs as a potential treatment for depression. How effective could they be, and what are the regulatory and legal challenges in their use?
Rapid response
What can deliberately infecting healthy people tell us about infectious diseases? How is this useful for developing treatments, and how do we manage the risks?
Rapid response
How do our bodies defend against Covid-19? Read how immune responses differ across people, variants, reinfection, vaccination, and current immunisation strategies.
Rapid response
A overview of science diplomacy, outlining its role in scientific collaborations and to support international diplomatic relationships, and a resume of recent developments.
Rapid response
Research studies involving thousands of people have allowed scientists to test which drugs are effective at treating COVID-19. Several drug therapies are now available to treat people who are in hospital with COVID-19, or to prevent infections in vulnerable people becoming more serious. This briefing explains which drugs are available, the groups of people in which they are used and how they work. It also outlines the importance of monitoring the emergence of new variants and drug resistance.
Rapid response
A new generation of COVID-19 vaccines could support vaccination strategies in the long term. But what are the latest developments from preclinical and clinical trials?
Total results (page 1 of 6)